ECSP024336A - A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY - Google Patents

A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY

Info

Publication number
ECSP024336A
ECSP024336A ECSP024336A ECSP024336A EC SP024336 A ECSP024336 A EC SP024336A EC SP024336 A ECSP024336 A EC SP024336A EC SP024336 A ECSP024336 A EC SP024336A
Authority
EC
Ecuador
Prior art keywords
dose unit
inflammatory
analgesic
procedure
type
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Zambrano Francisco Fernandez
Jose Luis Lauria
Enrique Jorge Podesta
Original Assignee
Roemmers Internat S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roemmers Internat S A filed Critical Roemmers Internat S A
Publication of ECSP024336A publication Critical patent/ECSP024336A/en

Links

Abstract

Se describe una forma de unidad de dosis farmacéutica del tipo de cápsulas de gelatina rígida que comprende clonixinato de lisina pulverizado como ingrediente activo, junto a exipientes farmacéuticos compatibles. De este modo se evita la comprensión, lo que da como resultado una mejora en la disolución y biodisponibilidad con respecto a otras formas farmacéuticas. Se describe además un procedimiento para preparar dicha unidad de dosis y el uso como analgésico y antiinflamatorio de la misma. Al no necesitarse compactar la mezcla a punta de transformarla en una unidad comprimida, ni suspenderla dentro de un exicipiente oleoso, produce una disolución más rápida al comienzo. Se mejora así su disponibilidad inicial, la cual pueda ser aprovechada para obtener un efecto rápido en el tratamiento del dolor o condiciones inflamatorias.A pharmaceutical dosage unit form of the type of rigid gelatin capsules comprising powdered lysine clonixinate as an active ingredient is described, together with compatible pharmaceutical excipients. This avoids understanding, which results in an improvement in dissolution and bioavailability with respect to other pharmaceutical forms. A procedure for preparing said dose unit and the use as an analgesic and anti-inflammatory thereof is also described. Since it is not necessary to compact the mixture to transform it into a compressed unit, or suspend it into an oily participant, it produces a faster dissolution at the beginning. This improves its initial availability, which can be used to obtain a rapid effect in the treatment of pain or inflammatory conditions.

ECSP024336 2001-11-22 2002-11-19 A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY ECSP024336A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA01011964 MXPA01011964A (en) 2001-11-22 2001-11-22 Rigid capsules pharmaceutical dose unit form containing lysine clonixinate, procedure for its preparation and the use of said dose unit as analgesic and/or anti-inflammatory.

Publications (1)

Publication Number Publication Date
ECSP024336A true ECSP024336A (en) 2003-05-26

Family

ID=33411824

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP024336 ECSP024336A (en) 2001-11-22 2002-11-19 A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY

Country Status (9)

Country Link
BR (1) BR0206122A (en)
CO (1) CO5380015A1 (en)
CR (1) CR6823A (en)
EC (1) ECSP024336A (en)
GT (1) GT200200218A (en)
MX (1) MXPA01011964A (en)
PA (1) PA8558401A1 (en)
PE (1) PE20030546A1 (en)
UY (1) UY27515A1 (en)

Also Published As

Publication number Publication date
BR0206122A (en) 2004-08-03
PE20030546A1 (en) 2003-08-12
CR6823A (en) 2008-08-27
PA8558401A1 (en) 2003-07-28
MXPA01011964A (en) 2003-08-20
GT200200218A (en) 2003-06-04
UY27515A1 (en) 2003-05-30
CO5380015A1 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
AR039744A1 (en) METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION
ES2167061T3 (en) DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS.
HRP20121072T1 (en) Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
AR065970A2 (en) A SOLID ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND GLIBENCLAMIDE AND USE OF SUCH COMPOSITION
BRPI0513200A (en) use of an anti-igf-1r antibody in the preparation of a medicament for combined treatment for nonhematological malignancies
AR005281A1 (en) ORAL PHARACEUTICAL COMPOSITION, PROCEDURES FOR ITS MANUFACTURE AND USE OF THAT PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF MEDICINES. .
CR7500A (en) DOSAGE FORMS OF AZITROMICIDE WITH REDUCED SIDE EFFECTS
AR040722A1 (en) FORMULATIONS AND DOSAGE FORMS FOR THE CONTROLLED ADMINISTRATION OF TOPIRAMATO
ATE308317T1 (en) PREPARATIONS CONTAINING AN ANTICHOLINERGIC ACTIVE INGREDIENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE
AR023806A1 (en) USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS
AR018862A1 (en) PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE, IMPROVED FOR THE ORAL ADMINISTRATION OF NEFAZODONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; ORAL DOSAGE FORM THAT UNDERSTANDS AND USE OF SUCH FORMULATION TO PREPARE THE SUCH DOSAGE FORM
ES2804324T3 (en) Compositions containing extracts of Curcuma longa and Echinacea angustifolia that are useful for reducing peripheral inflammation and pain
BR0115985A (en) Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
AR034813A1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
DE50203456D1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
AR061166A1 (en) PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF PHENYLPHERINE
AR045193A1 (en) FEXOFENADINE COMPOSITION AND PREPARATION PROCESS
AR033403A1 (en) USE OF REOVIRUS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO REDUCE A SOLID TUMOR MASS.
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
PE20130782A1 (en) PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME
ECSP024336A (en) A PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR PREPARATION AND THE USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR INFLAMMATORY
UY26595A1 (en) LOW DOSE USE USE FORMULATIONS
AR036009A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION
AR037542A1 (en) PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY
EA201290378A1 (en) COMPOSITIONS CONTAINING NESTEROIDIC ANTI-INFLAMMATORY MEDICINES